Export 9 results:
Author [ Title(Desc)] Type Year
Filters: Author is May, Jeanine  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
R. D. Hays, Tarver, M. E., Spritzer, K. L., Reise, S., Hilmantel, G., Hofmeister, E. M., Hammel, K., May, J., Ferris, F., and Eydelman, M., “Assessment of the Psychometric Properties of a Questionnaire Assessing Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL).”, JAMA Ophthalmol, vol. 135, no. 1, pp. 3-12, 2017.
C
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
D
K. V. Houser, Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., and Ledgerwood, J. E., “DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.”, PLoS One, vol. 13, no. 11, p. e0206837, 2018.
M
G. J. Gorse, Grimes, S., Buck, H., Mulla, H., White, P., Hill, H., May, J., Frey, S. E., and Blackburn, P., “MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System, With Reduced Seasonal Influenza Vaccine Hemagglutinin Dose May Enhance Potency, Durability and Cross-Reactivity of Antibody Responses in the Elderly”, Vaccine, vol. 40, no. 10, pp. 1472-1482, 2022.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., “Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.”, J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
N
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.”, Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
P
G. J. Gorse, Grimes, S., Buck, H., Mulla, H., White, P., Hill, H., May, J., Frey, S. E., and Blackburn, P., “A Phase 1 Dose-Sparing, Randomized Clinical Trial of Seasonal Trivalent Inactivated Influenza Vaccine Combined With MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System”, Vaccine, vol. 40, no. 9, pp. 1271-1281, 2022.
S
C. Carter, Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Chen, G. L., Patel, S. M., Winokur, P., Belshe, R., Dekker, C. L., Graham, B. S., and Ledgerwood, J. E., “Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.”, PLoS One, vol. 14, no. 9, p. e0222178, 2019.
M. Eydelman, Hilmantel, G., Tarver, M. E., Hofmeister, E. M., May, J., Hammel, K., Hays, R. D., and Ferris, F., “Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies.”, JAMA Ophthalmol, vol. 135, no. 1, pp. 13-22, 2017.